Pristimerin Inhibits Prostate Cancer Bone Metastasis by Targeting PC-3 Stem Cell Characteristics and VEGF-Induced Vasculogenesis of BM-EPCs - Concepedia

Concepedia

Publication | Open Access

Pristimerin Inhibits Prostate Cancer Bone Metastasis by Targeting PC-3 Stem Cell Characteristics and VEGF-Induced Vasculogenesis of BM-EPCs

DOI Full Paper Access

41

Citations

43

References

2015

Year

Shuai Huang, Peiheng He, Xinsheng Peng, Jinglei Li, Yubo Tang

Cellular Physiology and Biochemistry

Abstract

These data provide evidence that Pristimerin has strong potential for development as a novel agent against prostate bone metastasis by suppressing PC-3 stem cell characteristics and VEGF-induced vasculogenesis of BM-EPCs.

References

	Year	Citations

Page 1